Amgen (AMGN) Revenue & Quarterly History
Explore Amgen Inc. (AMGN) revenue from 2023 through the latest reported quarter, with SEC-sourced comparisons and filing-constrained analysis.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue declined from the prior quarter but increased compared to the same quarter last year. The sequential drop reflects typical seasonal patterns, while the year-over-year gain indicates underlying business growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$8.6B
Revenue reported for this quarter.
Quarter-over-quarter
-12.6%
Change from the immediately preceding quarter.
Year-over-year
+5.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$37.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $9.2B | +9.4% |
| Sep 30, 2025 | $9.6B | +12.4% |
| Dec 31, 2025 | $9.9B | +8.6% |
| Mar 31, 2026 | $8.6B | +5.8% |
Revenue performance
The reported revenue decreased from the immediately preceding quarter. This decline is consistent with the trend observed in the same period of prior years.
Quarterly comparison
Compared to the same quarter one year earlier, revenue was higher. The year-over-year improvement contrasts with the sequential decline, highlighting a mixed performance.
What to watch
Monitor whether the sequential revenue decline continues into the next quarter or stabilizes.